Evidence map›Paper›PMID 30870500›Full record

ArticlePloS one2019

QSAR modelling of a large imbalanced aryl hydrocarbon activation dataset by rational and random sampling and screening of 80,086 REACH pre-registered and/or registered substances.

Kyrylo Klimenko, Sine A Rosenberg, Marianne Dybdahl, Eva B Wedebye, Nikolai G Nikolov

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kyrylo KlimenkoDivision of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
Sine A RosenbergDivision of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
Marianne DybdahlDivision of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
Eva B WedebyeDivision of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
Nikolai G NikolovDivision of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0002-9212-9201

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Aryl hydrocarbon receptor (AhR) plays important roles in many normal and pathological physiological processes, including endocrine homeostasis, foetal development, cell cycle regulation, cellular oxidation/antioxidation, immune regulation, metabolism of endogenous and exogenous substances, and carcinogenesis. An experimental data set for human in vitro AhR activation comprising 324,858 substances, of which 1,982 were confirmed actives, was used to test an in-house-developed approach to rationally select Quantitative Structure-Activity Relationship (QSAR) training set substances from an unbalanced data set. In the first iteration, active and inactive substances were selected by random to make QSAR models. Then, more inactive substances were added to the training set in two further iterations based on incorrect or out-of-domain predictions to produce larger models. The resulting 'rational' model, comprising 832 actives and four times as many inactives, i.e. 3,328, was compared to a model with a training set of same size and proportion of inactives chosen entirely by random. Both models underwent robust cross-validation and external validation showing good statistical performance, with the rational model having external validation sensitivity of 85.1% and specificity of 97.1%, compared to the random model with sensitivity 89.1% and specificity 91.3%. Furthermore, we integrated the training sets for both models with the 93 external validation test set actives and 372 randomly selected inactives to make two final models. They also underwent external validations for specificity and cross-validations, which confirmed that good predictivity was maintained. All developed models were applied to predict 80,086 EU REACH substances. The rational and random final models had 63.1% and 56.9% coverage of the REACH set, respectively, and predicted 1,256 and 3,214 substances as actives. The final models as well as predictions for AhR activation for 650,000 substances will be published in the Danish (Q)SAR Database and can, for example, be used for priority setting, in read-across predictions and in weight-of-evidence assessments of chemicals.

Indexed as

AlgorithmsDatabases, FactualQuantitative Structure-Activity RelationshipHumansHydrocarbons, AromaticModels, MolecularReceptors, Aryl HydrocarbonHydrocarbons, AromaticReceptors, Aryl Hydrocarbon

Identifiers

PMID30870500
PMCPMC6417725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.